Search

Objective: To assess changes in incidence and mortality rates of colorectal cancer in different age groups in New South Wales (NSW) between 1973 and 1992., Design: Descriptive analysis of data on incidence and mortality from the population-based NSW Central Cancer Registry and on colorectal cancer diagnostic tests from the Health Insurance Commission., Main Outcome Measures: Age-standardised incidence and mortality rates for colon and rectal cancer (defined by codes 153 and 154 in the International classification of diseases, 9th revision) by sex and age group (15-44, 45-59, 60-74 or > or = 75 years) and incidence by cancer spread at diagnosis; age-standardised rates for faecal occult blood tests, sigmoidoscopy and colonoscopy., Results: From 1973 to 1992, colorectal cancer incidence increased significantly in NSW by an average of 2.0% per year in males (95% confidence interval [CI], 1.8 to 2.3) and 0.9% in females (95% CI, 0.7 to 1.1). Mortality rates remained nearly constant in males, but fell significantly in females by an average of -1.0% per year (95% CI, -1.3 to -0.7). In the youngest age group (15-44 years) both incidence and mortality rates fell significantly, while rates were stable or rose in older age groups, except for a significant fall in mortality in women aged > or = 75 years. Use of colonoscopy (an early detection method) increased, but a corresponding shift to detection of earlier-stage cancers was not seen., Conclusions: A reduction in risk factors and better treatment leading to longer survival may have contributed to the falls in incidence in younger people and in mortality in females.

Objective: To assess changes in cancer incidence and mortality in New South Wales (NSW) between 1973-1977 and 1988-1992., Design: Descriptive analysis of statutory cancer notifications to the NSW Central Cancer Registry., Outcome Measures: Age-standardised incidence and mortality rates calculated with the "world" standard population., Results: Overall cancer incidence rose markedly, from 251 to 318 per 100,000 in men and from 202 to 241 per 100,000 in women. The rise was greatest in the 60-and-over age group. Cancer mortality fell marginally in men (from 166 to 162 per 100,000) and did not change in women (100 per 100,000 in both periods). It fell in the under-60 age group, and remained stable or rose in older people. Prostate and breast cancers and melanoma of the skin accounted for about half the increase in incidence. Both incidence and mortality increased significantly (P < 0.01) for melanoma and non-Hodgkin's lymphomas in men and lung cancer in women, and fell substantially for stomach cancer in both sexes, lung cancer in men and cervical cancer in women. Despite increasing incidence, mortality, also fell for testicular cancer in men and rectal cancer in women and for leukaemias in children., Conclusions: The major factor causing the increased incidence of overall cancer was earlier detection. Altered exposure to risk factors could be identified for only a minority of the changes.

Several risk factors for breast cancer are readily identifiable, but most are not preventable. Hence the importance of screening, as early diagnosis and treatment offer the best hope of saving lives.

Objective: To determine whether there has been an increase in the proportion of small (< 1 cm in size) and localised breast cancers in women aged 50-69 (the group actively recruited to mammographic screening) compared with women aged 40-49., Design: Cases of invasive breast cancer in women aged 40-69 notified to the NSW Central Cancer Registry in 1986, 1989 and 1992 were included. Tumour sizes were determined from histopathology reports., Results: A higher percentage of breast cancers were under 1 cm in size in 1992 (10%) than in 1986 and 1989 (7%). The increase in the percentage of small breast cancers was statistically significant in women aged 50-69 (chi 2 for linear trend, 7.9; P = 0.005) but not in those aged 40-49 (chi 2 for linear trend, 2.5; P = 0.12). Slightly more than half the breast cancers (53%) in 1992 were localised to the breast, representing an increase from 49% in both 1986 and 1989. This increase was also statistically significant in women aged 50-69 (chi 2 for linear trend, 3.9; P = 0.05) but not in those aged 40-49 (chi 2 for linear trend, 1.4; P = 0.24)., Conclusions: Breast cancers in 1986, 1989 and 1992 showed a moderately strong shift to smaller tumours and localised disease in women aged 50-69. As women of this age group were targeted by mammographic screening, the widespread availability of mammography may explain this shift.

We recently have conducted a cross-sectional survey to determine the prescribing practices of rheumatologists and a random sample of general practitioners in New South Wales and Queensland. While in general there was agreement as to the preferred management of gout, several important differences were noted between the two groups of doctors. In particular, general practitioners were more liberal than were rheumatologists in their use of allopurinol. However, they were less likely to cover the introduction of allopurinol with anti-inflammatory agents, to titrate the dose against the serum uric acid level or to adjust the dose according to the serum creatinine level. A small number of doctors continued to use urate-lowering drugs as a routine in the treatment of entirely asymptomatic hyperuricaemia. The data indicate a continuing need to disseminate information regarding the preferred management of hyperuricaemic states.

A patient-completed questionnaire has been shown to be equivalent to an observer-administered format in discriminating between subjects with and without keratoconjunctivitis sicca. As well as saving time it can screen patients for the presence of keratoconjunctivitis sicca without the need for more specialized and/or invasive techniques.

In 1981, questionnaires seeking information about the teaching of medicine in general, and rheumatology in particular, were sent to random samples of undergraduates in Australian medical schools and trainees in the Family Medicine Programme (FMP) of the Royal Australian College of General Practitioners. Neurology rated most highly, with the majority of undergraduates considering it to be well taught and interesting; by contrast, rheumatology was perceived as being badly taught and lacking in interest. Many graduates had never attended rheumatology outpatient clinics either as undergraduates (45%) or as FMP trainees (68%). Only 40% of the graduates had ever been attached to a rheumatology inpatient service, and fewer than 50% had received any teaching about the role of physiotherapists or occupational therapists in the management of patients with arthritis.